Page 157 - Orange Book Cumulative Supplement 10 October 2012
P. 157
A - 20
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content
PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
FLUTICASONE FUROATE - VERAMYST
N022051 001 8062264 Apr 05, 2026 DP
8147461 Mar 10, 2025 DP
FLUTICASONE PROPIONATE - FLOVENT HFA
N021433 001 7832351 Jun 19, 2023 DP
7832351*PED Dec 19, 2023
FLUTICASONE PROPIONATE - FLOVENT HFA
N021433 002 7832351 Jun 19, 2023 DP
7832351*PED Dec 19, 2023
FLUTICASONE PROPIONATE - FLOVENT HFA
N021433 003 7832351 Jun 19, 2023 DP
7832351*PED Dec 19, 2023
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA
N021254 001 7832351 Jun 19, 2023 DP
7832351*PED Dec 19, 2023
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA
N021254 002 7832351 Jun 19, 2023 DP
7832351*PED Dec 19, 2023
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE - ADVAIR HFA
N021254 003 7832351 Jun 19, 2023 DP
7832351*PED Dec 19, 2023
FOSAMPRENAVIR CALCIUM - LEXIVA
N021548 001 NPP Apr 27, 2015
PED Oct 27, 2015
FOSAMPRENAVIR CALCIUM - LEXIVA
N022116 001 NPP Apr 27, 2015
PED Oct 27, 2015
FOSAPREPITANT DIMEGLUMINE - EMEND
N022023 002 5512570 Mar 04, 2014 U-850
5538982 Jul 23, 2013 U-850
5716942 Feb 10, 2015 U-850
7214692 Sep 18, 2012 U-850
FOSPROPOFOL DISODIUM - LUSEDRA
N022244 001 6204257 Jul 01, 2022 DS DP U-945
GABAPENTIN - GRALISE
N022544 001 8192756 Oct 25, 2022 DP U-1114
8252332 Oct 25, 2022 DP U-1114
GABAPENTIN - GRALISE
N022544 002 8192756 Oct 25, 2022 DP U-1114
8252332 Oct 25, 2022 DP U-1114
GABAPENTIN ENACARBIL - HORIZANT
N022399 001 8048917 Nov 06, 2022 DS DP U-1247 I-652 Jun 06, 2015
8114909 Apr 11, 2026 U-1231
